A popular muscle relaxer made in New Jersey is being recalled due to a label swap, according to the FDA. The product was ...

Inflammatory arthritis resulting from immune checkpoint inhibitor use is immunologically unique and likely driven by T cells ...

At week 52 in a randomized, controlled trial, results suggest that tocilizumab is more effective than methotrexate in ...

A machine learning model can use patient-reported data and remote therapeutic monitoring to accurately assess low disease ...

Topline data were announced from a phase 3 trial evaluating secukinumab in patients with polymyalgia rheumatica.

Weight loss drugs known as GLP-1 receptor agonists are sometimes referred to as “miracle drugs,” not only because they help people lose weight, but because they’ve also been shown to help with many ...

Among adults with type 2 diabetes, SGLT-2 inhibitors were linked to lower risk for autoimmune rheumatic diseases compared with sulfonylureas.

Physical therapy is routinely recommended for knee pain attributed to a degenerative meniscal tear, but its efficacy has not ...

Glucagon-like peptide 1 receptor agonists (GLP-1RA) have made waves as treatments for obesity and type 2 diabetes, but a new report suggests they might also have clinical benefits for certain patients ...

Rosnilimab acts as an agonist to stimulate PD-1, killing those cells with high PD-1 expression and pushing others into an ...

B/F/TAF shows lower ART switching rates and higher persistence among HIV patients, especially those with mental health or ...

According to study co-lead author Qizhi Qin, Ph.D., a postdoctoral fellow in the James Laboratory, the researchers also found ...